A study to see if the product makes your skin appear younger
- Registration Number
- CTRI/2024/03/064059
- Lead Sponsor
- Ichimaru Pharcos Co Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 38
1. Subjects in the age group of 20-55 years (both ages inclusive).
2. Subject presenting at least 2 well defined dark spots of PIH/Acne/Age spots on either side of the face.
3. Subject identified for fine lines of score 4 and above and wrinkles of score 2 and above
4. Subjects with skin phototype III to V. (10% of the subjects to be phototype V).
5. Subjects free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face as determined by the dermatologist.
6. Subject who agrees not to use any other product/treatment/home remedy/ except the provided product on their face during the study period other than the test product.
1.Subject with any other signs of significant local irritation or skin disease.
2. Subject currently taking any medication, which the Investigator believes may influence the interpretation of the data.
3. Subject having clinically significant systemic or cutaneous disease, chronic illness or had major surgery in the last year.
4. Subjects undergoing any treatment of any skin condition on their face.
5. Subjects not willing to discontinue other topical facial products.
6. Subject allergic or sensitive to bar, cleansing products, cosmetics, creams/lotions, artificial jewelry or anything else.
7. Subjects who are pregnant and lactating (Self- declared).
8. Subject who has participated in a similar clinical investigation in the past one month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Improvement in skin firmness or elasticity in comparison to baseline at different timepoints. <br/ ><br>2. Improvement in Wrinkles, Fine lines and Post Inflammatory Hyperpigmentation (Dark Spots) in comparison to Baseline at different timepoints. <br/ ><br>3. Improvement in hydration in comparison to untreated site and Baseline at different timepoints <br/ ><br>4. Improvement in the skin color in comparison to baseline at different timepoints.Timepoint: Baseline, 72hours, week 2 and week 4
- Secondary Outcome Measures
Name Time Method 1. To evaluate dermatological safety and tolerability of the test product for the entire study duration <br/ ><br>Timepoint: Baseline, 72hours, week 2 and week 4